Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Revenue (2020 - 2026)

Journey Medical filings provide 6 years of Revenue readings, the most recent being $15.5 million for Q4 2025.

  • On a quarterly basis, Revenue rose 22.5% to $15.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.6 million, a 9.97% increase, with the full-year FY2025 number at $61.2 million, up 11.07% from a year prior.
  • Revenue hit $15.5 million in Q4 2025 for Journey Medical, down from $17.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $23.3 million in Q1 2022 to a low of $10.7 million in Q1 2021.
  • Median Revenue over the past 5 years was $15.3 million (2023), compared with a mean of $15.5 million.
  • Biggest five-year swings in Revenue: soared 117.33% in 2022 and later tumbled 47.78% in 2023.
  • Journey Medical's Revenue stood at $17.5 million in 2021, then fell by 24.12% to $13.3 million in 2022, then grew by 14.78% to $15.3 million in 2023, then fell by 17.28% to $12.6 million in 2024, then grew by 22.5% to $15.5 million in 2025.
  • The last three reported values for Revenue were $15.5 million (Q4 2025), $17.0 million (Q3 2025), and $15.0 million (Q2 2025) per Business Quant data.